Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
D000328:Adult; D000347:Afibrinogenemia / Q000175:diagnosis; D001778:Blood Coagulation Disorders / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis / Q000096:biosynthesis; D006493:Heparin / Q000494:pharmacology; D006501:Hepatic Encephalopathy / Q000150:complications; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D011247:Pregnancy; D011248:Pregnancy Complications; D011517:Prothrombin Time; D013053:Spectrophotometry; D013917:Thrombin
D001779:Blood Coagulation Factors; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D013917:Thrombin